Impact of Tumor Burden Score on Conditional Survival after Curative‐Intent Resection for Hepatocellular Carcinoma: A Multi‐Institutional Analysis
Authors:
- 2 August 2021
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 45 (11) , 3438-3448
Abstract
Background: The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative‐intent resection of hepatocellular carcinoma (HCC) has not been examined to date.Methods: Patients who underwent liver resection of HCC between 2000 and 2017 were identified from a multi‐institutional database. The impact of TBS and other clinicopathologic factors on 3‐year conditional survival (CS3) was examined.Results: Among 1,040 patients, 263 (25.3%) patients had low TBS, 668 (64.2%) had medium TBS and 109 (10.5%) had high TBS. TBS was strongly associated with OS; 5‐year OS was 39.0% among patients with high TBS compared with 61.1% and 79.4% among patients with medium and low TBS, respectively (p < 0.001). While actuarial survival decreased as time elapsed from resection, CS increased over time irrespective of TBS. The largest differences between 3‐year actuarial survival and CS3 were noted among patients with high TBS (5‐years postoperatively; CS3: 78.7% vs. 3‐year actuarial survival: 30.7%). The effect of adverse clinicopathologic factors including high TBS, poor/undifferentiated tumor grade, microvascular invasion, liver capsule involvement, and positive margins on prognosis decreased over time.Conclusions: CS rates among patients who underwent resection for HCC increased as patients survived additional years, irrespective of TBS. CS estimates can be used to provide important dynamic information relative to the changing survival probability after resection of HCC.Keywords
This publication has 36 references indexed in Scilit:
- Dynamic prognostication using conditional survival estimatesCancer, 2013
- Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic PatientsClinical Cancer Research, 2012
- Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intentCancer, 2011
- Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07Journal of Clinical Oncology, 2010
- Novel advancements in the management of hepatocellular carcinoma in 2008Journal of Hepatology, 2008
- Prospective validation of the Barcelona Clinic Liver Cancer staging systemJournal of Hepatology, 2006
- Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 systemJournal of Hepato-Biliary-Pancreatic Surgery, 2005
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinomaBritish Journal of Surgery, 1996
- On the estimation of survivalSeminars in Surgical Oncology, 1994